Characterization of APOE and TOMM40 allele frequencies in the Japanese population

Abstract

IntroductionDementia is one of the major health threats to our aging society, and Alzheimer's disease (AD) is the leading cause. In Japan, ∼15% of the elderly population has dementia. The apolipoprotein E (APOE) genotype and a polymorphism (rs10524523) in the translocase of outer mitochondrial membrane 40 (TOMM40) gene have been associated with the age of onset of AD. However, differences in allele frequencies of these markers in different ethnic populations are not well known.MethodsWhole blood samples were collected from 300 Japanese subjects, and genomic DNA was extracted to determine APOE alleles and TOMM40 rs10524523 genotypes.ResultsOur results indicated that the APOE ε3–TOMM40′523 short haplotype is less frequent in Japanese subjects than in Caucasians, whereas the APOE ε3–TOMM40′523 long and APOE ε3–TOMM40′523 very long haplotypes are more frequent in Japanese subjects than in Caucasians. We also showed that the APOE ε4–TOMM40′523 short haplotype, which was noted to be frequently observed in African Americans, was also found in the Japanese population, although it is extremely rare in the Caucasian population.DiscussionA biomarker risk assignment algorithm, using a combination of APOE, TOMM40′523 genotype, and age, has been developed to assign near-term risk for developing the onset of mild cognitive impairment due to AD and is being used as an enrichment tool in an ongoing delay-of-onset clinical trial. Understanding the characterization of APOE and TOMM40 allele frequencies in the Japanese population is the first step in developing a risk algorithm for AD research and clinical applications for AD prevention in Japan.

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease

“…Analysis of the results collected for MCI and AD patients did not indicate that APOE ɛ4 carriers had higher plasma NFL than non-carriers. These findings are different from previous studies which suggested MCI patients had higher plasma NFL levels than HC and APOE ɛ4 carriers had higher plasma NFL than non-carriers 1 , which may reflect the highly nuanced and complex clinical entity in MCI 23 and relatively low proportion of APOE ɛ4 carriers among the Asian AD and MCI groups 24 – 27 .…”

Clinical ascertainment of health outcomes in Asian survivors of childhood cancer: a systematic review

“…Furthermore, inert genetic polymorphisms related to underlying diseases might determine susceptibility to the development of adverse outcomes associated with cancer treatment among survivors. The results of epidemiological studies of general populations suggest that the risk of neurocognitive deficits associated with apolipoprotein E polymorphisms differs among ethnic groups, such that stronger gene-disease associations were observed in Japanese subjects than in Caucasian subjects [ 94 , 95 ]. The systematic characterization of the genetic variability in treatment-related complications among Asian survivors is expected to have important clinical implications in this new era of precision medicine.…”

APOE Alleles and Diet in Brain Aging and Alzheimer’s Disease

“…Much less is known of other populations. The Japanese E3-'523S is less frequent than in Caucasians, whereas the E4-'523S is common as for African Americans (Nishimura et al, 2017).…”